MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, ANAB has $329,684K in assets. $248,469K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
758.02%
Quick Ratio
758.02%
Cash Ratio
595.82%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Short-term investments
    • Receivables from collaborative p...
    • Others
Liabilities Breakdown
    • Additional paid in capital
    • Accumulated deficit
    • Liability related to sale of fut...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
248,469 238,196 109,833 44,298
Receivables from collaborative partners
25,747 33,850 75,685 21,418
Short-term investments
37,986 73,442 139,123 221,412
Prepaid expenses and other current assets
3,907 4,762 6,009 4,778
Total current assets
316,109 350,250 330,650 291,906
Property and equipment, gross
8,549 8,509 --
Less accumulated depreciation and amortization
7,269 7,139 --
Property and equipment, net
1,280 1,370 1,500 1,628
Operating lease right-of-use assets
12,039 12,519 12,994 13,464
Long-term investments
-0 7,698 27,996
Other long-term assets
256 256 256 256
Total assets
329,684 364,395 353,098 335,250
Accounts payable
7,517 3,871 2,893 3,329
Accrued expenses
32,065 32,674 33,171 30,197
Current portion of operating lease liability
2,120 2,080 2,040 2,001
Total current liabilities
41,702 38,625 38,104 35,527
Liability related to sale of future royalties
263,742 276,528 331,844 331,361
Operating lease liability, net of current portion
11,493 12,032 12,566 13,095
Common stock, 0.001 par value, 500,000 shares authorized, 29,031 shares and 28,019 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively
29 28 28 28
Additional paid in capital
838,307 809,765 792,682 792,531
Accumulated other comprehensive loss
-146 -24 47 -6
Accumulated deficit
-825,443 -772,559 -822,173 -837,286
Total stockholders equity
12,747 37,210 -29,416 -44,733
Total liabilities and stockholders equity
329,684 364,395 353,098 335,250
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$248,469K Short-term investments$37,986K Receivables fromcollaborative partners$25,747K Prepaid expenses andother current assets$3,907K Property and equipment,gross$8,549K Total current assets$316,109K Operating leaseright-of-use assets$12,039K Property and equipment,net$1,280K Other long-termassets$256K Less accumulateddepreciation and...$7,269K Total assets$329,684K Total liabilities andstockholders equity$329,684K Liability related to saleof future...$263,742K Total currentliabilities$41,702K Total stockholdersequity$12,747K Operating leaseliability, net of current...$11,493K Accumulated deficit-$825,443K Accumulated othercomprehensive loss-$146K Accrued expenses$32,065K Accounts payable$7,517K Current portion ofoperating lease liability$2,120K Additional paid in capital$838,307K Common stock, 0.001 parvalue, 500,000 shares...$29K

ANAPTYSBIO, INC (ANAB)

ANAPTYSBIO, INC (ANAB)